Benzinga · Mar 5, 2026
OS
NASDAQ · OSRH
OSR Holdings, Inc.
Healthcare · Biotechnology
$0.28
Up+$0.03 (+11.66%)
Updated Aug 14, 2026, 8:19 PM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 16.52M
- P/E ratio
- -0.84
- Dividend yield
- 0.00%
- 52-week range
- $0.25 – $0.90
- Volume
- 1.19M
- Avg. volume
- 4.96M
Price performance
OSRH price history
1M range · 21 trading sessions · Daily adjusted prices
OSRH closed at $0.28 after 21 trading sessions, down 41.72% for the selected period.
- Last close
- $0.28
- Period change
- -41.72%
- Period low
- $0.28
- Period high
- $0.49
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $0.276 | $0.30 | $0.2545 | $0.283 | 1.19M |
| Aug 12, 2026 | $0.3916 | $0.40 | $0.2507 | $0.289 | 2.85M |
| Aug 11, 2026 | $0.411 | $0.4251 | $0.3852 | $0.386 | 688.31K |
| Aug 10, 2026 | $0.44 | $0.45 | $0.403 | $0.4106 | 472.27K |
| Aug 7, 2026 | $0.44 | $0.4499 | $0.43 | $0.443 | 167.25K |
| Aug 6, 2026 | $0.44 | $0.4472 | $0.4235 | $0.4362 | 213.87K |
| Aug 5, 2026 | $0.4528 | $0.4608 | $0.44 | $0.4422 | 192.42K |
| Aug 4, 2026 | $0.45 | $0.4692 | $0.4391 | $0.461 | 258.53K |
| Aug 3, 2026 | $0.441 | $0.4561 | $0.44 | $0.4461 | 333.17K |
| Jul 31, 2026 | $0.4311 | $0.4499 | $0.4111 | $0.448 | 476.35K |
| Jul 30, 2026 | $0.4732 | $0.4732 | $0.4281 | $0.43 | 525.64K |
| Jul 29, 2026 | $0.4689 | $0.50 | $0.46 | $0.474 | 722.15K |
| Jul 28, 2026 | $0.4311 | $0.4628 | $0.43 | $0.4566 | 276.01K |
| Jul 27, 2026 | $0.424 | $0.4462 | $0.4111 | $0.4331 | 292.49K |
| Jul 24, 2026 | $0.44 | $0.4567 | $0.4162 | $0.4228 | 270.27K |
| Jul 23, 2026 | $0.4355 | $0.45 | $0.4265 | $0.45 | 417.77K |
| Jul 22, 2026 | $0.425 | $0.4499 | $0.4102 | $0.439 | 502.49K |
| Jul 21, 2026 | $0.4585 | $0.4655 | $0.4253 | $0.4375 | 584.83K |
| Jul 20, 2026 | $0.4664 | $0.50 | $0.4515 | $0.4628 | 790.59K |
| Jul 17, 2026 | $0.498 | $0.4999 | $0.4516 | $0.4672 | 1.18M |
| Jul 16, 2026 | $0.43 | $0.5099 | $0.4152 | $0.4856 | 2.48M |
Latest OSRH news
The latest Smart Investors Daily articles mentioning OSRH.
Stock researchCompany · Overview
OSRH research
Overview
Company profile and research snapshot.
Company profile
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Benzinga · Mar 5, 2026
OSR Holdings Receives Written Notification From The Nasdaq Granting The Company An Additional 180-Calendar-Day Extension To Regain Compliance
OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare holding company advancing innovative biomedical technologies, today announced that it has received written notification from The Nasdaq Stock Market LLC granting the
GlobeNewswire Inc. · Dec 10, 2025
Presenting on Emerging Growth Conference 88 Day 2 on December 11; Register to live stream
EmergingGrowth.com announced the schedule for its 88th conference featuring presentations from multiple public companies across various sectors on December 10-11, 2025, providing investors an opportunity to learn about emerging growth companies.
globenewswire.com · Dec 9, 2025
Presenting on Emerging Growth Conference 88 Day 1 on December 10; Register to live stream
MIAMI, Dec. 09, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth. com a leading independent small cap media portal announces the schedule of the 88th Emerging Growth Conference on December 10 and 11, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products and services, focused strategy, execution, and the overall potential for long-term growth.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
